☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands | ||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
511 6th Ave #7342 New York, New York | 10011 | |
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant | FPAC.U | The New York Stock Exchange | ||
Class A ordinary shares | FPAC | The New York Stock Exchange | ||
Redeemable warrants exercisable for one Class A ordinary share at an exercise price of $11.50 | FPAC.W | The New York Stock Exchange |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
December 31, 2021 | September 30, 2021 | |||||||
(unaudited) | (audited) | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash | $ | 32,928 | $ | 172,454 | ||||
Prepaid expenses | 485,417 | 642,917 | ||||||
Total current assets | 518,345 | 815,371 | ||||||
Investments held in Trust Account | 600,221,029 | 600,209,262 | ||||||
Total Assets | $ | 600,739,374 | $ | 601,024,633 | ||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: | ||||||||
Current liabilities: | ||||||||
Accrued expenses | $ | 7,182,000 | $ | 5,155,500 | ||||
Accounts payable | 67,998 | 29,474 | ||||||
Total current liabilities | 7,249,998 | 5,184,974 | ||||||
Deferred legal fees | 400,000 | 400,000 | ||||||
Deferred underwriting commissions | 15,437,500 | 15,437,500 | ||||||
Derivative warrant liabilities | 53,730,000 | 46,710,000 | ||||||
Total liabilities | 76,817,498 | 67,732,474 | ||||||
Commitments and Contingencies | 0 | |||||||
Class A ordinary shares subject to possible redemption; 60,000,000 shares at $10.00 per share | 600,000,000 | 600,000,000 | ||||||
Shareholders’ Deficit | ||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; NaN issued or outstanding | 0— | 0 | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 0 non-redeemable shares issued or outstanding | 0 | 0 | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 9,750,000 shares issued and outstanding | 975 | 975 | ||||||
Additional paid-in capital | 0 | 0 | ||||||
Accumulated deficit | (76,079,099 | ) | (66,708,816 | ) | ||||
Total shareholders’ deficit | (76,078,124 | ) | (66,707,841 | ) | ||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | $ | 600,739,374 | $ | 601,024,633 | ||||
March 31, 2022 | September 30, 2021 | |||||||
(unaudited) | ||||||||
Assets | ||||||||
Current assets: | ||||||||
Cash | $ | 29,573 | $ | 172,454 | ||||
Prepaid expenses | 399,792 | 642,917 | ||||||
Total current assets | 429,365 | 815,371 | ||||||
Investments held in Trust Account | 600,229,415 | 600,209,262 | ||||||
Total Assets | $ | 600,658,780 | $ | 601,024,633 | ||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: | ||||||||
Current liabilities: | ||||||||
Accrued expenses | $ | 7,355,000 | $ | 5,155,500 | ||||
Accounts payable | 156,688 | 29,474 | ||||||
Total current liabilities | 7,511,688 | 5,184,974 | ||||||
Deferred legal fees | 400,000 | 400,000 | ||||||
Deferred underwriting commissions | 15,437,500 | 15,437,500 | ||||||
Derivative warrant liabilities | 44,227,328 | 46,710,000 | ||||||
Total liabilities | 67,576,516 | 67,732,474 | ||||||
Commitments and Contingencies | 0 | 0 | ||||||
Class A ordinary shares subject to possible redemption; 60,000,000 shares at $10.00 per share redemption value | 600,000,000 | 600,000,000 | ||||||
Shareholders’ Deficit | ||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; 0ne issued or outstanding | 0— | 0 | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 0 non-redeemable shares issued oroutstanding | 0 | 0 | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 9,750,000 shares issued and outstanding | 975 | 975 | ||||||
Additional paid-in capital | 0 | 0 | ||||||
Accumulated deficit | (66,918,711 | ) | (66,708,816 | ) | ||||
Total shareholders’ deficit | (66,917,736 | ) | (66,707,841 | ) | ||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | $ | 600,658,780 | $ | 601,024,633 | ||||
For the Three Months Ended December 31, 2021 | For the Period from October 19, 2020 (Inception) through December 31, 2020 | |||||||
General and administrative expenses | $ | 2,362,050 | $ | 662,301 | ||||
Loss on operations | (2,362,050 | ) | (662,301 | ) | ||||
Other income (expenses): | ||||||||
Change in fair value of derivative warrant liabilities | (7,020,000 | ) | 0 | |||||
Loss on sale of Private Placement Warrants | 0 | (3,500,000 | ) | |||||
Financing costs - derivative warrant liabilities | 0 | (1,684,760 | ) | |||||
Income (loss) from investments held in Trust Account | 11,767 | (23,369 | ) | |||||
Net loss | $ | (9,370,283 | ) | $ | (5,870,430 | ) | ||
Weighted average shares outstanding of Class A ordinary shares | 60,000,000 | 19,861,111 | ||||||
Basic and diluted net loss per ordinary share, Class A | $ | (0.13 | ) | $ | (0.20 | ) | ||
Weighted average shares outstanding of Class B ordinary shares | 9,750,000 | 9,750,000 | ||||||
Basic and diluted net loss per ordinary share, Class B | $ | (0.13 | ) | $ | (0.20 | ) | ||
For the Three Months Ended March 31, | For the Six Months Ended March 31, 2022 | For the Period From October 19, 2020 (inception) through March 31, 2021 | ||||||||||||||
2022 | 2021 | |||||||||||||||
General and administrative expenses | $ | 550,668 | $ | 822,254 | $ | 2,912,718 | $ | 1,484,555 | ||||||||
Loss on operations | (550,668 | ) | (822,254 | ) | (2,912,718 | ) | (1,484,555 | ) | ||||||||
Other income (expenses): | ||||||||||||||||
Change in fair value of derivative warrant liabilities | 9,684,670 | 24,300,000 | 2,664,670 | 24,300,000 | ||||||||||||
Loss on sale of Private Placement Warrants | 0 | 0 | 0 | (3,500,000 | ) | |||||||||||
Financing costs - derivative warrant liabilities | 0 | 0 | 0 | (1,684,760 | ) | |||||||||||
Income from investments held in Trust Account | 8,385 | 209,320 | 20,153 | 185,951 | ||||||||||||
Net income (loss) | $ | 9,142,387 | $ | 23,687,066 | $ | (227,896 | ) | $ | 17,816,636 | |||||||
Weighted average shares outstanding of Class A ordinary shares - Basic | 60,000,000 | 60,000,000 | 60,000,000 | 42,160,494 | ||||||||||||
Weighted average shares outstanding of Class A ordinary shares - Diluted | (60,000,000 | ) | (60,000,000 | ) | (60,000,000 | ) | 60,000,000 | |||||||||
Basic net income (loss) per ordinary share, Class A | $ | 0.13 | $ | 0.34 | $ | (0.00 | ) | $ | 0.34 | |||||||
Diluted net income (loss) per ordinary share, Class A | $ | 0.13 | $ | 0.34 | $ | (0.00 | ) | $ | 0.26 | |||||||
Weighted average shares outstanding of Class B ordinary shares - Basic and diluted | 9,750,000 | 9,750,000 | 9,750,000 | 9,750,000 | ||||||||||||
Basic net income (loss) per ordinary share, Class B | $ | 0.13 | $ | 0.34 | $ | (0.00 | ) | $ | 0.34 | |||||||
Diluted net income (loss) per ordinary share, Class B | $ | 0.13 | $ | 0.34 | $ | (0.00 | ) | $ | 0.26 | |||||||
Ordinary Shares | Additional | Total | ||||||||||||||||||||||||||
Class A | Class B | Paid-in | Accumulated | Shareholders’ | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||||||||
Balance - September 30, 2021 | 0 | $ | 0 | 9,750,000 | $ | 975 | $ | 0 | $ | (66,708,816 | ) | $ | (66,707,841 | ) | ||||||||||||||
Net loss | — | — | — | — | — | (9,370,283 | ) | (9,370,283 | ) | |||||||||||||||||||
Balance - December 31, 2021 (unaudited) | 0 | $ | 0 | 9,750,000 | $ | 975 | $ | 0 | $ | (76,079,099 | ) | $ | (76,078,124 | ) | ||||||||||||||
Ordinary Shares | Additional | Total | ||||||||||||||||||||||||||
Class A | Class B | Paid-in | Accumulated | Shareholders’ | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||||||||
Balance - September 30, 2021 | 0 | $ | 0 | 9,750,000 | $ | 975 | $ | 0 | $ | (66,708,816 | ) | $ | (66,707,841 | ) | ||||||||||||||
Net loss | — | — | — | — | — | (9,370,283 | ) | (9,370,283 | ) | |||||||||||||||||||
Balance - December 31, 2021 (unaudited) | 0 | 0 | 9,750,000 | 975 | 0 | (76,079,099 | ) | (76,078,124 | ) | |||||||||||||||||||
Excess cash received from private placement | — | — | — | — | 18,001 | — | 18,001 | |||||||||||||||||||||
Subsequent measurement of Class A ordinary shares subject to redemption against additional paid-in capital | — | — | — | — | (18,001 | ) | 18,001 | — | ||||||||||||||||||||
Net income | — | — | — | — | — | 9,142,387 | 9,142,387 | |||||||||||||||||||||
Balance - March 31, 2022 (unaudited) | 0 | $ | 0 | 9,750,000 | $ | 975 | $ | 0 | $ | (66,918,711 | ) | $ | (66,917,736 | ) | ||||||||||||||
Ordinary Shares | Additional | Total | ||||||||||||||||||||||||||
Class A | Class B | Paid-in | Accumulated | Shareholders’ | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||||||||
Balance - October 19, 2020 (inception) | 0 | $ | 0 | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||
Issuance of Class B ordinary shares to Sponsor | — | — | 9,750,000 | 975 | 24,025 | 0 | 25,000 | |||||||||||||||||||||
Accretion of Class A ordinary shares to redemption value | — | — | — | — | (24,025 | ) | (62,012,620 | ) | (62,036,645 | ) | ||||||||||||||||||
Net loss | — | — | — | — | — | (5,870,430 | ) | (5,870,430 | ) | |||||||||||||||||||
Balance - December 31, 2020 (unaudited) | 0 | $ | 0 | 9,750,000 | $ | 975 | $ | 0 | $ | (67,883,050 | ) | $ | (67,882,075 | ) | ||||||||||||||
Ordinary Shares | Additional | Total | ||||||||||||||||||||||||||
Class A | Class B | Paid-in | Accumulated | Shareholders’ | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||||||||
Balance - October 19, 2020 (inception) | 0 | $ | 0 | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||
Issuance of Class B ordinary shares to Sponsor | — | — | 9,750,000 | 975 | 24,025 | 0 | 25,000 | |||||||||||||||||||||
Accretion of Class A ordinary shares to redemption value | — | — | — | — | (24,025 | ) | (62,012,620 | ) | (62,036,645 | ) | ||||||||||||||||||
Net loss | — | — | — | — | — | (5,870,430 | ) | (5,870,430 | ) | |||||||||||||||||||
Balance - December 31, 2020 (unaudited) | 0 | 0 | 9,750,000 | 975 | 0 | (67,883,050 | ) | (67,882,075 | ) | |||||||||||||||||||
Net income | — | — | — | — | — | 23,687,066 | 23,687,066 | |||||||||||||||||||||
Balance - March 31, 2021 (unaudited) | 0 | $ | 0 | 9,750,000 | $ | 975 | $ | 0 | $ | (44,195,984 | ) | $ | (44,195,009 | ) | ||||||||||||||
For the Three Months Ended December 31, 2021 | For the Period from October 19, 2020 (Inception) through December 31, 2020 | |||||||
Cash Flows from Operating Activities: | ||||||||
Net loss | $ | (9,370,283 | ) | $ | (5,870,430 | ) | ||
Adjustments to reconcile net loss to cash used in operating activities: | ||||||||
General and administrative expenses paid by Sponsor under promissory note | 0 | 31,015 | ||||||
Change in fair value of derivative warrant liabilities | 7,020,000 | 0 | ||||||
Financing costs - derivative warrant liabilities | — | 1,684,760 | ||||||
Loss (income) from investments held in Trust Account | (11,767 | ) | 23,369 | |||||
Loss on sale of Private Placement warrants | 0 | 3,500,000 | ||||||
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses | 157,500 | (857,475 | ) | |||||
Accrued expenses | 2,026,500 | 435,000 | ||||||
Accounts payable | 38,524 | 125,666 | ||||||
Net cash used in operating activities | (139,526 | ) | (928,095 | ) | ||||
Cash Flows from Investing Activities: | ||||||||
Cash deposited in Trust Account | 0 | (600,000,000 | ) | |||||
Net cash used in investing activities | 0 | (600,000,000 | ) | |||||
Cash Flows from Financing Activities: | ||||||||
Repayment of note payable to related party | 0 | (195,396 | ) | |||||
Proceeds received from initial public offering, gross | 0 | 600,000,000 | ||||||
Proceeds received from private placement | 0 | 10,500,000 | ||||||
Offering costs paid | 0 | (11,219,524 | ) | |||||
Reimbursement from underwriters | 0 | 3,600,000 | ||||||
Net cash provided by financing activities | 0 | 602,685,080 | ||||||
Net change in cash | (139,526 | ) | 1,756,985 | |||||
Cash - beginning of the period | 172,454 | 0 | ||||||
Cash - end of the period | $ | 32,928 | $ | 1,756,985 | ||||
Supplemental disclosure of noncash financing activities: | ||||||||
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | $ | 0 | $ | 25,000 | ||||
Offering costs included in accrued expenses | $ | 0 | $ | 750,000 | ||||
Offering costs funded with note payable - related party | $ | — | $ | 164,381 | ||||
Deferred legal fees | $ | 0 | $ | 400,000 | ||||
Deferred underwriting commissions | $ | 0 | $ | 15,437,500 |
For the Six Months Ended March 31, 2022 | For the Period From October 19, 2020 (inception) through March 31, 2021 | |||||||
Cash Flows from Operating Activities: | ||||||||
Net income (loss) | $ | (227,896 | ) | $ | 17,816,636 | |||
Adjustments to reconcile net income (loss) to cash used in operating activities: | ||||||||
General and administrative expenses paid by Sponsor under promissory note | 0 | 31,014 | ||||||
Change in fair value of derivative warrant liabilities | (2,664,670 | ) | (24,300,000 | ) | ||||
Financing costs - derivative warrant liabilities | — | 1,684,760 | ||||||
I ncome from investments held in Trust Account | (20,153 | ) | (185,951 | ) | ||||
Loss on sale of Private Placement warrants | 0 | 3,500,000 | ||||||
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses | 243,125 | (846,241 | ) | |||||
Accrued expenses | 2,199,500 | 835,000 | ||||||
Accounts payable | 127,214 | 160,416 | ||||||
Net cash used in operating activities | (342,880 | ) | (1,304,366 | ) | ||||
Cash Flows from Investing Activities: | ||||||||
Cash deposited in Trust Account | 0 | (600,000,000 | ) | |||||
Net cash used in investing activities | 0 | (600,000,000 | ) | |||||
Cash Flows from Financing Activities: | ||||||||
Repayment of note payable to related party | 0 | (195,396 | ) | |||||
Proceeds received from initial public offering, gross | 0 | 600,000,000 | ||||||
Proceeds received from private placement | 199,999 | 10,500,000 | ||||||
Offering costs paid | 0 | (11,219,524 | ) | |||||
Reimbursement from underwriters | 0 | 3,600,000 | ||||||
Net cash provided by financing activities | 199,999 | 602,685,080 | ||||||
Net change in cash | (142,881 | ) | 1,380,714 | |||||
Cash - beginning of the period | 172,454 | 0 | ||||||
Cash - end of the period | $ | 29,573 | $ | 1,380,714 | ||||
Supplemental disclosure of noncash financing activities: | ||||||||
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | $ | 0 | $ | 25,000 | ||||
Offering costs included in accrued expenses | $ | 0 | $ | 75,000 | ||||
Offering costs funded with note payable - related party | $ | 0 | $ | 164,381 | ||||
Deferred legal fees | $ | 0 | $ | 400,000 | ||||
Deferred underwriting commissions | $ | 0 | $ | 15,437,500 | ||||
Subsequent measurement of Class A ordinary shares subject to redemption against additional paid-in capital | $ | 18,001 | $ | 0 |
For the Three Months Ended March 31, 2022 | For the Three Months Ended March 31, 2021 | |||||||||||||||||||||||||||||||
For the Three Months | For the Period from October 19, 2020 | Class A | Class B | Class A | Class B | |||||||||||||||||||||||||||
Ended December 31, 2021 | (Inception) through December 31, 2020 | |||||||||||||||||||||||||||||||
Class A | Class B | Class A | Class B | |||||||||||||||||||||||||||||
Basic and diluted net loss per ordinary share: | ||||||||||||||||||||||||||||||||
Basic and diluted net income per ordinary share: | ||||||||||||||||||||||||||||||||
Numerator: | ||||||||||||||||||||||||||||||||
Allocation of net loss | $ | (8,060,458 | ) | $ | (1,309,825 | ) | $ | (3,937,484 | ) | $ | (1,932,946 | ) | ||||||||||||||||||||
Allocation of net income | $ | 7,864,419 | $ | 1,277,968 | $ | 20,375,971 | $ | 3,311,095 | ||||||||||||||||||||||||
Denominator: | ||||||||||||||||||||||||||||||||
Basic and diluted weighted average ordinary shares outstanding | �� | 60,000,000 | 9,750,000 | 19,861,111 | 9,750,000 | 60,000,000 | 9,750,000 | 60,000,000 | 9,750,000 | |||||||||||||||||||||||
Basic and diluted net loss per ordinary share | $ | (0.13 | ) | $ | (0.13 | ) | $ | (0.20 | ) | $ | (0.20 | ) | ||||||||||||||||||||
Basic and diluted net income per ordinary share | $ | 0.13 | $ | 0.13 | $ | 0.34 | $ | 0.34 | ||||||||||||||||||||||||
For the Six Months Ended March 31, 2022 | For the Period From October 19, 2020 (inception) through March 31, 2021 | |||||||||||||||
Class A | Class B | Class A | Class B | |||||||||||||
Basic and diluted net income (loss) per ordinary share: | ||||||||||||||||
Numerator: | ||||||||||||||||
Allocation of net income (loss) - basic | $ | (196,040 | ) | $ | (31,856 | ) | $ | 14,470,257 | $ | 3,346,379 | ||||||
Allocation of net income (loss) - diluted | $ | (196,040 | ) | $ | (31,856 | ) | $ | 15,326,138 | $ | 2,490,498 | ||||||
Denominator: | ||||||||||||||||
Basic weighted average ordinary shares outstanding | 60,000,000 | 9,750,000 | 42,160,494 | 9,750,000 | ||||||||||||
Diluted weighted average ordinary shares outstanding | 60,000,000 | 9,750,000 | 60,000,000 | 9,750,000 | ||||||||||||
Basic net income (loss) per ordinary share | $ | (0.00 | ) | $ | (0.00 | ) | $ | 0.34 | $ | 0.34 | ||||||
Diluted net income (loss) per ordinary share | $ | (0.00 | ) | $ | (0.00 | ) | $ | 0.26 | $ | 0.26 | ||||||
�� | • | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30 -trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
Gross proceeds from Initial Public Offering | $ | 600,000,000 | ||
Less: | ||||
Fair value of Public Warrants at issuance | (40,000,000 | ) | ||
Offering costs allocated to Class A ordinary shares subject to possible redemption | (22,036,645 | ) | ||
Plus: | ||||
Accretion on Class A ordinary shares subject to possible redemption amount | 62,036,645 | |||
Class A ordinary shares subject to possible redemption | $ | 600,000,000 | ||
Description | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||
Assets: | ||||||||||||
Investments held in Trust Account-money market fund | $ | 600,221,029 | $ | 0 | $ | 0 | ||||||
Liabilities: | ||||||||||||
Derivative warrant liabilities-Public warrants | $ | 39,800,000 | $ | 0 | $ | 0 | ||||||
Derivative warrant liabilities-Private warrants | $ | 0 | $ | 13,930,000 | $ | 0 |
Description | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||
Assets: | ||||||||||||
Investments held in Trust Account-money market fund | $ | 600,229,415 | $ | 0 | $ | 0 | ||||||
Liabilities: | ||||||||||||
Derivative warrant liabilities-Public warrants | $ | 32,600,000 | $ | 0 | $ | 0 | ||||||
Derivative warrant liabilities-Private warrants | $ | 0 | $ | 11,627,328 | $ | 0 |
Description | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||
Assets: | ||||||||||||
Investments held in Trust Account-money market fund | $ | 600,209,262 | $ | 0 | $ | 0 | ||||||
Liabilities: | ||||||||||||
Derivative warrant liabilities-Public warrants | $ | 34,600,000 | $ | 0 | $ | 0 | ||||||
Derivative warrant liabilities-Private warrants | $ | 0 | $ | 12,110,000 | $ | 0 |
Item 3. Quantitative and Qualitative Disclosures About Market Risk |
Item 4. Controls and Procedures |
Item 1. Legal Proceedings |
Item 1A. Risk Factors. |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
* | Filed herewith. |
** | Furnished. |
(1) | Previously filed as an exhibit to our Current Report on Form 8-K filed on December 7, 2020 and incorporated by reference herein. |
Far Peak Acquisition Corporation | ||
By: | /s/ Thomas W. Farley | |
Name: | Thomas W. Farley | |
Title: | Chief Executive Officer | |
By: | /s/ David W. Bonanno | |
Name: | David W. Bonanno | |
Title: | Chief Financial Officer |